ProCE Banner Activity

My Take on Long-Acting Therapies for People With Growth Hormone Deficiency

Clinical Thought
Here’s my perspective on how new, long-acting growth hormone preparations may be used for managing patients with growth hormone deficiency.

Released: February 24, 2022

Expiration: February 23, 2023

No longer available for credit.

Share

Faculty

Kevin C.J. Yuen

Kevin C.J. Yuen, MD, FRCP (UK), FACE

Professor of Medicine
Department of Neuroendocrinology and Neurosurgery
Barrow Neurological Institute
Medical Director
Barrow Neuroendocrinology Clinic
Barrow Pituitary Center
Phoenix, Arizona

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Novo Nordisk

Partners

Endocrine Nurses Society

ProCE Banner

National Alliance Adolescent Health

ProCE Banner

Faculty Disclosure

Primary Author

Kevin C.J. Yuen, MD, FRCP (UK), FACE

Professor of Medicine
Department of Neuroendocrinology and Neurosurgery
Barrow Neurological Institute
Medical Director
Barrow Neuroendocrinology Clinic
Barrow Pituitary Center
Phoenix, Arizona

Kevin C.J. Yuen, MD, FRCP (UK), FACE, has disclosed that he has received funds for research support from Amryt, Ascendis, Corcept, and Crinetics; consulting fees from Amryt, Ascendis, Corcept, Crinetics, Ipsen, Novo Nordisk, Recordati, and Strongbridge; and fees for non-CME/CE services from Corcept, Ipsen, and Novo Nordisk.